BARBOLINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.350
EU - Europa 1.562
AS - Asia 571
SA - Sud America 15
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 2
Totale 4.519
Nazione #
US - Stati Uniti d'America 2.330
IT - Italia 529
IE - Irlanda 311
GB - Regno Unito 225
CN - Cina 155
SG - Singapore 135
SE - Svezia 127
DE - Germania 106
HK - Hong Kong 83
FI - Finlandia 58
FR - Francia 46
ID - Indonesia 42
TR - Turchia 35
BE - Belgio 26
JP - Giappone 24
BG - Bulgaria 23
UA - Ucraina 23
IN - India 22
VN - Vietnam 18
CA - Canada 17
LT - Lituania 17
TW - Taiwan 16
MY - Malesia 14
CZ - Repubblica Ceca 12
IR - Iran 12
RU - Federazione Russa 12
NL - Olanda 11
BR - Brasile 10
EU - Europa 9
AU - Australia 8
AL - Albania 7
PL - Polonia 6
ES - Italia 5
MT - Malta 5
CR - Costa Rica 3
RO - Romania 3
SA - Arabia Saudita 3
AR - Argentina 2
GR - Grecia 2
IQ - Iraq 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
EC - Ecuador 1
ET - Etiopia 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZM - Zambia 1
Totale 4.519
Città #
Santa Clara 380
Chandler 310
Dublin 310
Fairfield 219
Ashburn 169
Southend 150
Nyköping 112
Woodbridge 112
Singapore 106
Ann Arbor 99
Seattle 91
Wilmington 88
Hong Kong 80
Houston 75
Cambridge 72
Modena 62
Dearborn 59
Helsinki 57
New York 50
Jakarta 41
Beijing 40
Jacksonville 37
Bologna 34
Fremont 34
Milan 32
San Diego 28
Redwood City 27
Princeton 23
Sofia 23
Brussels 21
San Giuliano Milanese 19
Shanghai 19
Bremen 17
Dong Ket 17
London 17
Rome 17
Reggio Emilia 16
Eugene 15
Parma 15
Falls Church 14
Munich 12
Paris 12
New Taipei 11
Izmir 10
Moscow 9
Brno 8
Caprarola 8
Guangzhou 8
Los Angeles 8
Tokyo 8
Norwalk 7
Santorso 7
Sassuolo 7
Shinjuku 7
Venezia 7
Boardman 6
Castelvetrano 6
Des Moines 6
Florence 6
Istanbul 6
Vernon 6
Aydin 5
Bomporto 5
Changchun 5
Napoli 5
Padova 5
Palermo 5
Savona 5
Taipei 5
Toronto 5
Vicenza 5
Amsterdam 4
Bagnara di Romagna 4
Brooklyn 4
Carpi 4
Dallas 4
Genoa 4
Kunming 4
Lüleburgaz 4
Melbourne 4
Mesagne 4
Ottawa 4
Tirana 4
Wandsworth 4
Breganze 3
Bussolengo 3
Chengdu 3
Chicago 3
Coral Springs 3
Frankfurt am Main 3
Hefei 3
Kilburn 3
Monza 3
Mumbai 3
Naples 3
Osaka 3
Presezzo 3
Rabat 3
San José 3
Sint-pieters-leeuw 3
Totale 3.422
Nome #
GD2 expression in breast cancer. 311
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 244
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 240
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 232
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 222
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 212
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 211
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 204
A concise review of lenalidomide therapy for follicular lymphoma 201
The evolving role of microsatellite instability in colorectal cancer: A review 190
Breast Location for De Novo Extramedullary Myeloid Sarcoma 189
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 182
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 164
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 149
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 148
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 146
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 146
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 133
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 131
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 127
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 127
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 120
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 113
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 88
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 72
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 65
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 57
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 51
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 42
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 31
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 24
Totale 4.572
Categoria #
all - tutte 17.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020330 0 0 0 0 0 72 96 45 41 19 31 26
2020/2021614 57 62 39 79 83 60 19 58 32 42 35 48
2021/2022625 43 79 34 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/2025789 58 35 61 119 325 191 0 0 0 0 0 0
Totale 4.572